Provided by Tiger Trade Technology Pte. Ltd.

GENSCRIPT BIO

34.440
+1.0803.24%
Volume:34.78M
Turnover:1.19B
Market Cap:75.70B
PE:-17.87
High:34.760
Open:33.200
Low:32.500
Close:33.360
52wk High:35.220
52wk Low:10.360
Shares:2.20B
HK Float Shares:2.20B
Volume Ratio:0.51
T/O Rate:1.58%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.927
ROE:-15.33%
ROA:1.54%
PB:2.48
PE(LYR):-17.87
PS:11.43

Loading ...

GenScript seeks shareholder approval for bylaw updates on hybrid meetings, e-voting, treasury shares

Reuters
·
Apr 10

GenScript partners with Mimulus to scale DNA-based data storage by 2030

Reuters
·
Apr 09

HK Movers | Pharmaceutical Stocks Rally With Joinn up 7%

Tiger Newspress
·
Apr 09

Genscript Bio Adds 1.53 Million New Shares in March 2026, Issued Capital Reaches 2.19 Billion

Bulletin Express
·
Apr 02

Jefferies Adjusts Yeahka's Price Target to HK$15.50 From HK$23, Keeps at Buy

MT Newswires Live
·
Apr 02

GENSCRIPT BIO (01548) 2025 Annual Report Review: Synergistic Growth Across Three Core Businesses Highlights Systemic Competitive Advantages and Long-Term Value

Stock News
·
Mar 18

Daiwa Cuts Target Price for GENSCRIPT BIO (01548) to HK$21, Reiterates "Buy" Rating

Stock News
·
Mar 18

Revised title

Deep News
·
Mar 18

Genscript Biotech Losses Narrow Sharply In First Half Reinforcing Profitability Narrative

Simply Wall St.
·
Mar 18

GENSCRIPT BIO (01548) Surges Over 5% on Strong Annual Revenue Growth and Narrowed Losses at Legend Biotech

Stock News
·
Mar 17

Stock Track | GENSCRIPT BIO Soars 5.08% Intraday on Underlying Sales Growth and European mRNA Expansion

Stock Track
·
Mar 17

Genscript’s 2025 Profit Swing And mRNA Expansion Might Change The Case For Investing In Genscript Biotech (SEHK:1548)

Simply Wall St.
·
Mar 17

BRIEF-Genscript Biotech Corp Reports Strong Fy2025 Results As Integrated Platform Strategy And Global Execution Drive High-Quality Growth

Reuters
·
Mar 16

Genscript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth

THOMSON REUTERS
·
Mar 16

GENSCRIPT BIO (01548.HK) Announces Company Secretary Transition: Sophie Lam Appointed, Wai Ling Wong Resigns

Bulletin Express
·
Mar 15

GENSCRIPT BIO (01548) Appoints New Company Secretary

Stock News
·
Mar 15

GenScript Biotech appoints Lam Wai Yee Sophie as company secretary, replacing Wong Wai Ling

Reuters
·
Mar 15

GenScript Biotech FY2025 adjusted net profit tripled to USD 230.35 million, revenue rose 61% to USD 959.53 million

Reuters
·
Mar 15

Morgan Stanley Adjusts GENSCRIPT BIO (01548) Target Price to HK$16.5, Keeps "Overweight" Stance

Stock News
·
Mar 11

Genscript Biotech Forecasts 2025 Loss

MT Newswires Live
·
Mar 11